PubRank

A R Ronald

Author PubWeight™ 246.27‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Female to male transmission of human immunodeficiency virus type 1: risk factors for seroconversion in men. Lancet 1989 11.39
2 Cofactors in male-female sexual transmission of human immunodeficiency virus type 1. J Infect Dis 1991 7.05
3 A critical evaluation of nalidixic acid in urinary-tract infections. N Engl J Med 1966 5.80
4 Genital ulceration as a risk factor for human immunodeficiency virus infection. AIDS 1988 4.85
5 AIDS virus infection in Nairobi prostitutes. Spread of the epidemic to East Africa. N Engl J Med 1986 4.68
6 Male circumcision: assessment of health benefits and risks. Sex Transm Infect 1998 4.59
7 Human immunodeficiency virus infection among men with sexually transmitted diseases. Experience from a center in Africa. N Engl J Med 1988 4.55
8 Comparison of specimen collection and laboratory techniques for isolation of Haemophilus ducreyi. J Clin Microbiol 1978 4.20
9 Geographical patterns of male circumcision practices in Africa: association with HIV seroprevalence. Int J Epidemiol 1990 3.63
10 The interaction of HIV infection and other sexually transmitted diseases: an opportunity for intervention. AIDS 1989 3.48
11 Antimicrobial susceptibility of Haemophilus ducreyi. Antimicrob Agents Chemother 1978 3.23
12 Epidemiologic, clinical, laboratory, and therapeutic features of an urban outbreak of chancroid in North America. Rev Infect Dis 1981 2.89
13 Determination of the hemin requirement of Haemophilus ducreyi: evaluation of the porphyrin test and media used in the satellite growth test. J Clin Microbiol 1978 2.37
14 Prevention of transmission of human immunodeficiency virus in Africa: effectiveness of condom promotion and health education among prostitutes. Lancet 1988 2.33
15 Prophylaxis of gonococcal and chlamydial ophthalmia neonatorum. A comparison of silver nitrate and tetracycline. N Engl J Med 1988 2.20
16 The association of urinary tract infection with sexual intercourse. J Infect Dis 1982 2.05
17 Factors influencing in vitro susceptibility to the cephalosporins and clinical trial of an oral cephalosporin, cephaloglycin. Antimicrob Agents Chemother (Bethesda) 1966 1.99
18 Bacteriuria localization and response to single-dose therapy in women. JAMA 1976 1.98
19 Antimicrobial therapy of chancroid: an evaluation of five treatment regimens correlated with in vitro sensitivity. Sex Transm Dis 1983 1.92
20 Prostitutes are a major reservoir of sexually transmitted diseases in Nairobi, Kenya. Sex Transm Dis 1985 1.91
21 Human immunodeficiency virus type 1 seroconversion in women with genital ulcers. J Infect Dis 1994 1.85
22 Plasmid-mediated ampicillin resistance in Haemophilus ducreyi. Antimicrob Agents Chemother 1979 1.85
23 Kanamycin sulfate in the treatment of acute gonorrheal urethritis in men. JAMA 1968 1.84
24 Resistance of gram-negative bacilli to gentamicin. J Infect Dis 1971 1.82
25 The association between lack of male circumcision and risk for HIV infection: a review of the epidemiological data. Sex Transm Dis 1994 1.79
26 A controlled study of antimicrobial prophylaxis of recurrent urinary infection in women. N Engl J Med 1974 1.74
27 Human immunodeficiency virus type 1 infection in women attending a sexually transmitted diseases clinic in Kenya. J Infect Dis 1992 1.70
28 Influence of mucoidy on antibody coating of Pseudomonas aeruginosa. J Infect Dis 1979 1.67
29 Epidemiology of ophthalmia neonatorum in Kenya. Lancet 1986 1.66
30 Characterization of cell proteins of Haemophilus ducreyi by polyacrylamide gel electrophoresis. J Infect Dis 1983 1.65
31 A prospective controlled investigation of prophylactic trimethoprim/sulfamethoxazole in hospitalized granulocytopenic patients. Am J Med 1979 1.64
32 Treatment of chancroid by clavulanic acid with amoxycillin in patients with beta-lactamase-positive Haemophilus ducreyi infection. Lancet 1982 1.58
33 Epidemiology of chancroid and Haemophilus ducreyi in Nairobi, Kenya. Lancet 1983 1.57
34 A randomized, placebo-controlled trial of monthly azithromycin prophylaxis to prevent sexually transmitted infections and HIV-1 in Kenyan sex workers: study design and baseline findings. Int J STD AIDS 2000 1.55
35 Relationship between lipopolysaccharide composition and virulence of Haemophilus ducreyi. J Med Microbiol 1987 1.55
36 Single-dose therapy of chancroid with trimethoprim-sulfametrole. N Engl J Med 1983 1.52
37 Chancroid and the role of genital ulcer disease in the spread of human retroviruses. Med Clin North Am 1990 1.46
38 The plasmids of Haemophilus ducreyi. J Antimicrob Chemother 1984 1.44
39 Comparison of media for the primary isolation of Haemophilus ducreyi. Sex Transm Dis 1984 1.43
40 Increased risk of infection with human immunodeficiency virus type 1 among uncircumcised men presenting with genital ulcer disease in Kenya. Clin Infect Dis 1996 1.43
41 Bacteremic Haemophilus influenzae genitourinary tract infections in adults. Arch Intern Med 1978 1.43
42 Emergence of gentamicin- and carbenicillin-resistant Pseudomonas aeruginosa in a hospital environment. Antimicrob Agents Chemother 1976 1.42
43 Virulence factors of Haemophilus ducreyi. Infect Immun 1984 1.41
44 Relapse and reinfection in chronic bacteriuria. II. The correlation between site of infection and pattern of recurrence in chronic bacteriuria. N Engl J Med 1968 1.40
45 Characterization of ampicillin resistance plasmids of Haemophilus ducreyi and Neisseria gonorrhoeae with regard to location of origin of transfer and mobilization by a conjugative plasmid of Haemophilus ducreyi. J Bacteriol 1983 1.37
46 Susceptibility of Neisseria gonorrhoeae to penicillin and tetracycline. Antimicrob Agents Chemother (Bethesda) 1968 1.36
47 Biotyping of Escherichia coli by a simple multiple-inoculation agar plate technique. J Clin Microbiol 1979 1.36
48 Detection of human immunodeficiency virus type 1 (HIV-1) in genital ulcer exudate of HIV-1-infected men by culture and gene amplification. J Infect Dis 1990 1.33
49 Postpartum upper genital tract infections in Nairobi, Kenya: epidemiology, etiology, and risk factors. J Infect Dis 1987 1.32
50 The clinical diagnosis of genital ulcer disease in men in the tropics. Sex Transm Dis 1984 1.31
51 Urinary tract infection localization in women. JAMA 1978 1.30
52 Humoral immune response of humans to lipooligosaccharide and outer membrane proteins of Haemophilus ducreyi. J Infect Dis 1993 1.29
53 Role of lipopolysaccharide and complement in susceptibility of Haemophilus ducreyi to human serum. Infect Immun 1985 1.27
54 Antimicrobial misuse--effects and suggestions for control. J Antimicrob Chemother 1979 1.25
55 Isolation and immunological characterization of a unique toxic cytoplasmic polymer of type 1 Neisseria gonorrhoeae. Can J Microbiol 1974 1.22
56 Therapy for acute cystitis in adult women. Randomized comparison of single-dose sulfisoxazole vs trimethoprim-sulfamethoxazole. JAMA 1982 1.21
57 Effect of bacteriuria on renal concentrating mechanisms. Ann Intern Med 1969 1.19
58 Standardization of an enzyme immunoassay for human antibody to Haemophilus ducreyi. J Clin Microbiol 1992 1.17
59 How long should catheter-acquired urinary tract infection in women be treated? A randomized controlled study. Ann Intern Med 1991 1.15
60 Clinical and microbiologic studies of genital ulcers in Kenyan women. Sex Transm Dis 1986 1.14
61 Single-dose kanamycin therapy of gonococcal ophthalmia neonatorum. Lancet 1984 1.13
62 Evaluation of fleroxacin (RO 23-6240) as single-oral-dose therapy of culture-proven chancroid in Nairobi, Kenya. Antimicrob Agents Chemother 1989 1.13
63 Prophylaxis of recurrent urinary tract infection in female patients. Efficacy of low-dose, thrice-weekly therapy with trimethoprim-sulfamethoxazole. JAMA 1979 1.13
64 Role of ceftriaxone in sexually transmitted diseases. Rev Infect Dis 1989 1.13
65 Antimicrobial therapy of chancroid: effectiveness of erythromycin. J Infect Dis 1983 1.10
66 Prospective, randomized comparative study of clindamycin, chloramphenicol, and ticarcillin, each in combination with gentamicin, in therapy for intraabdominal and female genital tract sepsis. J Infect Dis 1980 1.09
67 Anaerobic and aerobic urethral flora in healthy females. J Clin Microbiol 1978 1.07
68 Comparison of three serological tests in gonococcal infection. Appl Microbiol 1974 1.06
69 Comparative activities of norfloxacin and fifteen other antipseudomonal agents against gentamicin-susceptible and -resistant Pseudomonas aeruginosa strains. Antimicrob Agents Chemother 1983 1.06
70 The management of urinary infections: what have we learned in the past decade? Int J Antimicrob Agents 1994 1.06
71 Treatment of chancroid with ciprofloxacin. A prospective, randomized clinical trial. Am J Med 1987 1.06
72 The treatment of chancroid: comparison of one week of sulfisoxazole with single dose doxycycline. J Antimicrob Chemother 1979 1.05
73 Recurrent urinary tract infection in adult women: diagnosis and treatment. Infect Dis Clin North Am 1987 1.05
74 Cerebrospinal fluid as a diagnostic body fluid. Am J Med 1983 1.04
75 Condom use prevents genital ulcers in women working as prostitutes. Influence of human immunodeficiency virus infection. Sex Transm Dis 1991 1.04
76 Human immunodeficiency virus, genital ulcers and the male foreskin: synergism in HIV-1 transmission. Scand J Infect Dis Suppl 1990 1.04
77 Comparative trial of norfloxacin and trimethoprim-sulfamethoxazole in the treatment of women with localized, acute, symptomatic urinary tract infections and antimicrobial effect on periurethral and fecal microflora. Antimicrob Agents Chemother 1984 1.02
78 Plasmid-mediated tetracycline resistance in Haemophilus ducreyi. Antimicrob Agents Chemother 1984 1.02
79 Chancroid and Haemophilus ducreyi. Ann Intern Med 1985 0.99
80 Synergistic antibacterial activity of clavulanic acid and amoxicillin against beta-lactamase-producing strains of Haemophilus ducreyi. Antimicrob Agents Chemother 1981 0.99
81 Urine screening with the MS-2. J Clin Microbiol 1983 0.99
82 Advances in the diagnosis and management of chancroid. Sex Transm Dis 1986 0.98
83 A comparison of the in vitro activity of rosamicin, erythromycin, clindamycin, metroidazole and ornidazole against Haemophilus ducreyi, including beta-lactamase producing strains. J Antimicrob Chemother 1979 0.98
84 Treatment of chancroid. A comparison of sulphamethoxazole and trimethoprim-sulphamethoxazole. Br J Vener Dis 1983 0.98
85 Identification of a ROB-1 beta-lactamase in Haemophilus ducreyi. Antimicrob Agents Chemother 1992 0.98
86 Prospective, randomized, placebo-controlled trial of norfloxacin for the prophylaxis of recurrent urinary tract infection in women. Antimicrob Agents Chemother 1989 0.98
87 Granulocytopenia in hospitalized patients. II. A prospective comparison of two antibiotic regimens in the empiric therapy of febrile patients. Am J Med 1978 0.97
88 Once-daily therapy with ceftriaxone compared with daily multiple-dose therapy with cefotaxime for serious bacterial infections: a randomized, double-blind study. J Infect Dis 1989 0.97
89 Clinical and laboratory experience with clindamycin. Antimicrob Agents Chemother (Bethesda) 1970 0.97
90 Etiology of nonvesicular genital ulcers in Winnipeg. Sex Transm Dis 1987 0.97
91 Studies on the epidemiology of Escherichia coli, 1960-1968. J Infect Dis 1969 0.96
92 Ampicillin-resistant H. influenzae subdural empyemia following successful treatment of apparently ampicillin-sensitive H. influenzae meningitis. J Pediatr 1977 0.96
93 Urinary infection localization. Am J Obstet Gynecol 1972 0.96
94 Evaluation of new anti-infective drugs for the treatment of sexually transmitted chlamydial infections and related clinical syndromes. Infectious Diseases Society of America and the Food and Drug Administration. Clin Infect Dis 1992 0.96
95 Clinical experiences: genitourinary infections. A. Infections of the urinary tract. Efficacy of trimethoprim-sulfamethoxazole in bacteriuria. J Infect Dis 1973 0.95
96 Advances in the treatment of urinary tract infection. Am J Med 1984 0.94
97 Prospective randomized comparison of imipenem/cilastatin and cefotaxime for treatment of lung, soft tissue, and renal infections. Rev Infect Dis 1985 0.94
98 Clinical evaluation of rosoxacin for the treatment of chancroid. Antimicrob Agents Chemother 1986 0.94
99 Pharmacologic studies of amoxicillin in nonfasting adults. J Infect Dis 1974 0.94
100 Emergence of rifampin-resistant Haemophilus influenzae. Antimicrob Agents Chemother 1982 0.94
101 A multicentre prospective randomized trial comparing ceftazidime with cefazolin/tobramycin in the treatment of hospitalized patients with non-pneumococcal pneumonia. J Antimicrob Chemother 1983 0.94
102 Evaluation of new anti-infective drugs for the treatment of genital infections due to herpes simplex virus. Infectious Diseases Society of America and the Food and Drug Administration. Clin Infect Dis 1992 0.94
103 Clinical and in situ cellular responses to Haemophilus ducreyi in the presence or absence of HIV infection. Int J STD AIDS 1998 0.93
104 Granulocytopenia in hospitalized patients: I. Prognostic factors and etiology of fever. Am J Med 1978 0.93
105 Chancroid. A newly important sexually transmitted disease. Arch Dermatol 1989 0.93
106 Long-term antimicrobial prophylaxis for recurrent urinary tract infection in women. Rev Infect Dis 1982 0.92
107 Treating chancroid with enoxacin. Genitourin Med 1988 0.91
108 Use of an adsorption enzyme immunoassay to evaluate the Haemophilus ducreyi specific and cross-reactive humoral immune response of humans. Sex Transm Dis 1993 0.91
109 Clinical efficacy and toxicity of netilmicin in the treatment of gram-negative infections. Can Med Assoc J 1979 0.91
110 A prospective randomized trial of ceftazidime versus cefazolin/tobramycin in the treatment of hospitalized patients with pneumonia. J Antimicrob Chemother 1987 0.91
111 Infection and disease after perinatal exposure to Chlamydia trachomatis in Nairobi, Kenya. J Infect Dis 1988 0.91
112 Herpes zoster as the initial presentation of human immunodeficiency virus type 1 infection in Kenya. Clin Infect Dis 1995 0.91
113 Amoxicillin therapy of acute urinary infections in adults. Antimicrob Agents Chemother 1977 0.91
114 Nystatin prophylaxis of fungal colonization and infection in granulocytopenic patients: correlation of colonization and clinical outcome. Clin Invest Med 1985 0.90
115 Ceftriaxone no longer predictably cures chancroid in Kenya. J Infect Dis 1993 0.90
116 Efficacy of five years of continuous, low-dose trimethoprim-sulfamethoxazole prophylaxis for urinary tract infection. J Infect Dis 1988 0.90
117 A randomized, double-blind study of the efficacy of fleroxacin versus trimethoprim-sulfamethoxazole in men with culture-proven chancroid. J Infect Dis 1992 0.90
118 Cefotaxime treatment of Haemophilus ducreyi infection in Kenya. Sex Transm Dis 1985 0.90
119 A comparison of the efficacy of nalidixic acid and cephalexin in bacteriuric women and their effect on fecal and periurethral carriage of enterobacteriaceae. J Infect Dis 1981 0.90
120 Investigations of the occurrence of gentamicin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 1979 0.89
121 Single-dose ceftriaxone for chancroid. Antimicrob Agents Chemother 1987 0.88
122 Susceptibility of Enterobacteriaceae to nitrofurantoin correlated with eradication of bacteriuria. Antimicrob Agents Chemother (Bethesda) 1966 0.88
123 Single-dose therapy with trimethoprim-sulfametrole for chancroid in females. Sex Transm Dis 1986 0.87
124 A comparison of single-dose spectinomycin with five days of trimethoprim-sulfamethoxazole for the treatment of chancroid. Sex Transm Dis 1987 0.87
125 Single-dose therapy of gonococcal ophthalmia neonatorum with ceftriaxone. N Engl J Med 1986 0.87
126 Current concepts in the management of urinary tract infections in adults. Med Clin North Am 1984 0.87
127 Gentamicin in the treatment of gonorrhoea in females. Br J Vener Dis 1974 0.86
128 Isolation and identification of Haemophilus ducreyi in a clinical laboratory. J Med Microbiol 1986 0.86
129 A randomized, double-blind, placebo-controlled trial of single-dose ciprofloxacin versus erythromycin for the treatment of chancroid in Nairobi, Kenya. J Infect Dis 1999 0.86
130 Field testing of modified Bieling media for the isolation of Haemophilus ducreyi in Kenya. Eur J Clin Microbiol 1986 0.86
131 Evaluation of new anti-infective drugs for the treatment of uncomplicated gonorrhea in adults and adolescents. Infectious Diseases Society of America and the Food and Drug Administration. Clin Infect Dis 1992 0.85
132 Glucose-6-phosphate dehydrogenase deficiency in Pakistani males. Trans R Soc Trop Med Hyg 1968 0.85
133 Short-course and single-dose antimicrobial therapy for chancroid in Kenya: studies with rifampin alone and in combination with trimethoprim. Rev Infect Dis 1983 0.85
134 Bacteremia due to Bacteroidacceae: a review of 92 cases. J Infect Dis 1977 0.85
135 In vitro activity of ceftriaxone, cefetamet (Ro 15-8074), ceftetrame (Ro 19-5247; T-2588), and fleroxacin (Ro 23-6240; AM-833) versus Neisseria gonorrhoeae and Haemophilus ducreyi. Antimicrob Agents Chemother 1987 0.85
136 Three day oral course of Augmentin to treat chancroid. Genitourin Med 1986 0.85
137 Single-dose versus traditional therapy for uncomplicated urinary tract infections. Drug Intell Clin Pharm 1988 0.84
138 Urinary infection prophylaxis in women. Ann Intern Med 1981 0.84
139 Randomized controlled trial comparing trimethoprim/sulfamethoxazole and trimethoprim for infection prophylaxis in hospitalized granulocytopenic patients. Am J Med 1984 0.84
140 Topical gentamicin therapy on the burn wound. Plast Reconstr Surg 1970 0.84
141 Ampicillin-resistant strains of Hemophilus influenzae. Can Med Assoc J 1975 0.83
142 Transfer of plasmid-mediated ampicillin resistance from Haemophilus to Neisseria gonorrhoeae requires an intervening organism. Sex Transm Dis 1986 0.83
143 Origin and direction of in vitro replication of Haemophilus ducreyi and Neisseria gonorrhoeae ampicillin resistance plasmids. J Bacteriol 1984 0.82
144 Role of cervicovaginal antibody in the pathogenesis of recurrent urinary tract infection in women. Infect Immun 1980 0.82
145 Identification of highly conserved and species-specific polypeptides of Haemophilus ducreyi. J Med Microbiol 1992 0.82
146 The reappearance of the specialty devoted to infectious disease. Can Med Assoc J 1978 0.82
147 Characterization of a Haemophilus ducreyi mobilizing plasmid. J Bacteriol 1986 0.82
148 Comparison of Sheffield media with standard media for the isolation of Haemophilus ducreyi. Sex Transm Dis 1989 0.82
149 An approach to urinary tract infections in ambulatory women. Curr Clin Top Infect Dis 1988 0.82
150 Serum antibody response in renal versus bladder bacteriuria. J Infect Dis 1971 0.81
151 Antimicrobial prophylaxis in surgery. Surgery 1983 0.81
152 Production of monoclonal antibodies specific for Haemophilus ducreyi: a screening method to discriminate specific and cross-reacting antibodies. Hybridoma 1989 0.81
153 A review of HIV-1 in Africa. Bull N Y Acad Med 1989 0.81
154 Clinical evaluation of amikacin in treatment of infections due to gram-negative aerobic bacilli. J Infect Dis 1976 0.81
155 Prolonged outbreak of nosocomial urinary tract infection with a single strain of Pseudomonas aeruginosa. Can Med Assoc J 1978 0.80
156 Emergence of tobramycin-resistant S. epidermidis possessing aminoglycoside modifying enzymes and bacteremic superinfection during empiric therapy of febrile neutropenic episodes. Clin Invest Med 1985 0.80
157 Double-blind, randomized comparison of 24 weeks of norfloxacin and 12 weeks of norfloxacin followed by 12 weeks of placebo in the therapy of complicated urinary tract infection. Antimicrob Agents Chemother 1988 0.80
158 Clinical and laboratory study of tobramycin in the treatment of infections due to gram-negative organisms. Can Med Assoc J 1977 0.80
159 Antibacterial chemoprophylaxis in neutropenic patients--where do we go from here? Clin Infect Dis 1993 0.80
160 Bacterial endocarditis due to hemophilus aphrophilus. Can Med Assoc J 1970 0.79
161 Low dose erythromycin regimen for the treatment of chancroid. East Afr Med J 1995 0.79
162 Failure of urinary beta-glucuronidase activity to localize the site of urinary tract infection. Appl Microbiol 1971 0.79
163 Trimethoprim-rifampin, a new combination agent: efficacy in localized urinary infection and influence on microflora. Antimicrob Agents Chemother 1981 0.78
164 Single dose azithromycin for the treatment of chancroid: a randomized comparison with erythromycin. Sex Transm Dis 1994 0.78
165 Herpes simplex virus in clinically suspected chancroid in Nairobi, Kenya. Afr J Sex Transmi Dis 1985 0.78
166 A comparison of trimethorprim-sulfamethoxazole with sulfamethoxazole alone in infections localized to the kidneys. Can Med Assoc J 1975 0.78
167 Prophylaxis of recurring urinary tract infection in females: a comparison of nitrofurantoin with trimethoprim-sulfamethoxazole. Can Med Assoc J 1975 0.78
168 Urethral infection with Haemophilus ducreyi in men. Sex Transm Dis 1988 0.78
169 The role of the laboratory in a Chlamydia control programme in a developing country. East Afr Med J 1992 0.77
170 Reduction in mortality from gram-negative sepsis in neutropenic patients receiving trimethoprim/sulfamethoxazole therapy. Cancer 1983 0.77
171 The correlation between site on infection and maximal concentrating ability in bacteriuria. J Infect Dis 1969 0.77
172 Immune response to a purified cytoplasmic protein of Neisseria gonorrhoeae. Br J Vener Dis 1976 0.77
173 Accuracy and costs of rapid human immunodeficiency virus testing technologies in rural hospitals in Zambia. Sex Transm Dis 1998 0.77
174 Resistance to aminoglycoside antibiotics of gram-negative bacilli isolated in Canadian hospitals. Can Med Assoc J 1981 0.77
175 Optimal duration of treatment for kidney infection. Ann Intern Med 1987 0.77
176 Acquired immunodeficiency syndrome: epidemiology in Africa and its implications for health services. Afr J Sex Transmi Dis 1986 0.76
177 Norfloxacin: its potential in clinical practice. Am J Med 1987 0.76
178 Evaluation of new anti-infective drugs for the treatment of vaginal infections. Infectious Diseases Society of America and the Food and Drug Administration. Clin Infect Dis 1992 0.76
179 Fleroxacin in the treatment of chancroid: an open study in men seropositive or seronegative for the human immunodeficiency virus type 1. Am J Med 1993 0.76
180 Urinary tract infections: the efficacy of trimethoprim/sulfamethoxazole. Clin Ther 1980 0.76
181 Adherence of Escherichia coli to epithelial cells in the pathogenesis of urinary tract infection. Clin Invest Med 1985 0.75
182 Editorial: urinary tract infection. Can Med Assoc J 1975 0.75
183 Chronic cystitis: a non-diagnosis. Can Fam Physician 1982 0.75
184 Herpes simplex encephalitis: poor outcome despite adenine arabinoside therapy. Can Med Assoc J 1982 0.75
185 Comparison of norfloxacin versus nalidixic acid in therapy of acute urinary tract infections. Can J Infect Dis 1990 0.75
186 Heterosexual transmission of human immunodeficiency virus infection - Strategies for prevention. Can J Infect Dis 1991 0.75
187 Legionnaires' disease in a renal transplant recipient. Can Med Assoc J 1979 0.75
188 Comparison of silver sulfadiazine and gentamicin for topical prophylaxis against burn wound sepsis. Can Med Assoc J 1978 0.75
189 Trimethoprim-resistant Enterobacteriaceae in urinary tract infection. Can Med Assoc J 1975 0.75
190 Infectious diseases as a subspecialty in Canada: reply. Rev Infect Dis 1992 0.75
191 Rarer infectious diseases. Can Fam Physician 1980 0.75
192 The correlation between site of infection and pattern of recurrence in chronic bacteriuria. Trans Assoc Am Physicians 1967 0.75
193 Sexual behavior and perceived risk of AIDS among men in Kenya attending a clinic for sexually transmitted diseases. Clin Infect Dis 1994 0.75
194 Epidemiologic features of urinary infections due to enterobacteriaceae resistant to nalidixic acid and trimethoprim. Scand J Infect Dis 1981 0.75
195 Trimethoprim alone in the treatment and prophylaxis of urinary tract infection. Arch Intern Med 1981 0.75
196 Research on sexually transmitted diseases in Canada. Can J Public Health 1983 0.75
197 Seroprevalence and demographic information of patients at risk for human immunodeficiency virus (HIV) infection in Manitoba, Canada. J Acquir Immune Defic Syndr 1988 0.75
198 Sexually transmitted diseases in Kenya. Kenya Nurs J 1985 0.75
199 Pros and cons of antimicrobial prophylaxis in surgery. Can J Surg 1981 0.75
200 The management of urethrocystitis in women. Semin Urol 1983 0.75
201 Treatment of uncomplicated gonorrhea in women with a single dose of amoxicillin. J Infect Dis 1974 0.75
202 Laboratory diagnosis of chancroid in Nairobi, Kenya. East Afr Med J 1986 0.75
203 The 1991 Thomas Parran Award Allan R. Ronald. Dr. Ronald's remarks made on receipt of the Parran Award. Sex Transm Dis 1993 0.75
204 The diagnosis and management of urinary infection in females. Del Med J 1971 0.75
205 Cell-mediated immune response in gonococcal infection. Can J Microbiol 1981 0.75
206 Chancroid. Recent advances in treatment and control. Int J Dermatol 1986 0.75
207 Localization of urinary infection. Antimicrob Agents Chemother (Bethesda) 1970 0.75
208 Urinary tract infection. Appl Ther 1968 0.75
209 Special issues in clinical trials of new anti-infective drugs for the treatment of sexually transmitted diseases. Infectious Diseases Society of America and the Food and Drug Administration. Clin Infect Dis 1992 0.75
210 Antimicrobial therapy in patients sensitive to penicillin. J Chronic Dis 1967 0.75
211 Topical gentamicin in burns. Antimicrob Agents Chemother (Bethesda) 1969 0.75
212 Antimicrobial cream susceptibility testing. Burns Incl Therm Inj 1985 0.75
213 Ceftazidime therapy versus aminoglycoside therapy in patients with gram-negative burn wound infections. J Burn Care Rehabil 1987 0.75
214 Two cases of Hemophilus endocarditis of prolapsed mitral valves--Hemophilus paraphrophilus or parainfluenzae? Am J Med 1978 0.75
215 Comparison of oxafuradene and nitrofurantoin in vitro and clinical assessment of oxafuradene in bacteriuria. Antimicrob Agents Chemother (Bethesda) 1967 0.75
216 Antimicrobial susceptibility testing--its value and limitations in medical practice. Del Med J 1971 0.75